Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Candidatus Mycoplasma haemohominis in Human, Japan.

Hattori N, Kuroda M, Katano H, Takuma T, Ito T, Arai N, Yanai R, Sekizuka T, Ishii S, Miura Y, Tokunaga T, Watanabe H, Nomura N, Eguchi J, Hasegawa H, Nakamaki T, Wakita T, Niki Y.

Emerg Infect Dis. 2020 Jan;26(1):11-19. doi: 10.3201/eid2601.190983.

2.

Great Oxidation and Lomagundi events linked by deep cycling and enhanced degassing of carbon.

Eguchi J, Seales J, Dasgupta R.

Nat Geosci. 2019;Dec 2019. doi: 10.1038/s41561-019-0492-6. Epub 2019 Dec 2.

PMID:
31807138
3.

The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer's disease in rodents.

Griebel G, Stemmelin J, Lopez-Grancha M, Boulay D, Boquet G, Slowinski F, Pichat P, Beeské S, Tanaka S, Mori A, Fujimura M, Eguchi J.

Sci Rep. 2019 Dec 2;9(1):18045. doi: 10.1038/s41598-019-54557-5.

4.

The Ability for Basic Movement Scale II Can Predict Functional Outcome and Discharge Destination in Stroke Patients.

Yang G, Gu R, Sato S, Zheng F, Sano M, Yashima C, Eguchi J, Ishida T, Kawaguchi M, Kubo J, Kakuda W.

J Stroke Cerebrovasc Dis. 2020 Jan;29(1):104484. doi: 10.1016/j.jstrokecerebrovasdis.2019.104484. Epub 2019 Nov 18.

PMID:
31753717
5.

Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reports.

Arai J, Shimozuma Y, Otoyama Y, Sugiura I, Nakajima Y, Hayashi E, Kajiwara A, Omori R, Uozumi S, Miyashita M, Uchikoshi M, Doi H, Sakaki M, Wang T, Eguchi J, Ito T, Kurihara T, Munechika J, Gokan T, Saito K, Miura S, Tate G, Takimoto M, Yoshida H.

BMC Gastroenterol. 2019 Nov 14;19(1):187. doi: 10.1186/s12876-019-1113-y.

6.

A Patient with Type 3 Autoimmune Polyglandular Syndrome who Developed Systemic Lupus Erythematosus 8 years after the Diagnosis of Autoimmune Hepatitis.

Mifune-Morioka T, Uchida HA, Fukushima K, Watanabe M, Ouchi C, Mise K, Kawakita C, Kano Y, Onishi A, Toma K, Eguchi J, Wada N, Ikeda F, Sasaki E, Suganami Y, Kishida M, Sugiyama H, Okada H, Wada J.

Acta Med Okayama. 2019 Aug;73(4):367-372. doi: 10.18926/AMO/56940.

7.

Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports.

Shibata Y, Nakatsuka A, Eguchi J, Miyamoto S, Masuda Y, Awazawa M, Takaki A, Yoshida R, Yagi T, Wada J.

J Med Case Rep. 2018 Dec 14;12(1):368. doi: 10.1186/s13256-018-1901-y.

8.

GPIHBP1 autoantibody syndrome during interferon β1a treatment.

Eguchi J, Miyashita K, Fukamachi I, Nakajima K, Murakami M, Kawahara Y, Yamashita T, Ohta Y, Abe K, Nakatsuka A, Mino M, Takase S, Okazaki H, Hegele RA, Ploug M, Hu X, Wada J, Young SG, Beigneux AP.

J Clin Lipidol. 2019 Jan - Feb;13(1):62-69. doi: 10.1016/j.jacl.2018.10.004. Epub 2018 Oct 24.

9.

Renal expression of trefoil factor 3 mRNA in association with tubulointerstitial fibrosis in IgA nephropathy.

Tanaka K, Sugiyama H, Yamanari T, Mise K, Morinaga H, Kitagawa M, Onishi A, Ogawa-Akiyama A, Tanabe K, Eguchi J, Ohmoto Y, Shikata K, Wada J.

Nephrology (Carlton). 2018 Sep;23(9):855-862. doi: 10.1111/nep.13444. Epub 2018 Jul 26.

10.

Identification of Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling in a Multicenter Prospective Cohort Study: U-CARE Study 1.

Mise K, Imamura M, Yamaguchi S, Teshigawara S, Tone A, Uchida HA, Eguchi J, Nakatsuka A, Ogawa D, Yoshida M, Yamada M, Shikata K, Wada J.

Diabetes Care. 2018 Aug;41(8):1765-1775. doi: 10.2337/dc18-0030. Epub 2018 Jun 21.

PMID:
29930140
11.

Three-dimensional architecture of the whole human soleus muscle in vivo.

Bolsterlee B, Finni T, D'Souza A, Eguchi J, Clarke EC, Herbert RD.

PeerJ. 2018 Apr 18;6:e4610. doi: 10.7717/peerj.4610. eCollection 2018.

12.

Enhanced B-cell differentiation driven by advanced cirrhosis resulting in hyperglobulinemia.

Doi H, Hayashi E, Arai J, Tojo M, Morikawa K, Eguchi J, Ito T, Kanto T, Kaplan DE, Yoshida H.

J Gastroenterol Hepatol. 2018 Feb 10. doi: 10.1111/jgh.14123. [Epub ahead of print]

13.

Effect of an enhanced recovery after surgery protocol in patients undergoing pancreaticoduodenectomy: A randomized controlled trial.

Takagi K, Yoshida R, Yagi T, Umeda Y, Nobuoka D, Kuise T, Hinotsu S, Matsusaki T, Morimatsu H, Eguchi J, Wada J, Senda M, Fujiwara T.

Clin Nutr. 2019 Feb;38(1):174-181. doi: 10.1016/j.clnu.2018.01.002. Epub 2018 Jan 9.

PMID:
29373148
14.

Association of TUSC1 and DPF3 gene polymorphisms with male infertility.

Sato Y, Hasegawa C, Tajima A, Nozawa S, Yoshiike M, Koh E, Kanaya J, Namiki M, Matsumiya K, Tsujimura A, Komatsu K, Itoh N, Eguchi J, Yamauchi A, Iwamoto T.

J Assist Reprod Genet. 2018 Feb;35(2):257-263. doi: 10.1007/s10815-017-1052-x. Epub 2017 Oct 3.

15.

Discovery of novel 2-(3-phenylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors.

Usui Y, Uehara F, Hiki S, Watanabe K, Tanaka H, Shouda A, Yokoshima S, Aritomo K, Adachi T, Fukunaga K, Sunada S, Nabeno M, Saito KI, Eguchi JI, Yamagami K, Asano S, Tanaka S, Yuki S, Yoshii N, Fujimura M, Horikawa T.

Bioorg Med Chem Lett. 2017 Aug 15;27(16):3726-3732. doi: 10.1016/j.bmcl.2017.06.078. Epub 2017 Jul 5.

PMID:
28712708
16.

Discovery of novel 2-(4-aryl-2-methylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors.

Kohara T, Nakayama K, Watanabe K, Kusaka SI, Sakai D, Tanaka H, Fukunaga K, Sunada S, Nabeno M, Saito KI, Eguchi JI, Mori A, Tanaka S, Bessho T, Takiguchi-Hayashi K, Horikawa T.

Bioorg Med Chem Lett. 2017 Aug 15;27(16):3733-3738. doi: 10.1016/j.bmcl.2017.06.077. Epub 2017 Jul 5.

PMID:
28712706
17.

An independent validation study of three single nucleotide polymorphisms at the sex hormone-binding globulin locus for testosterone levels identified by genome-wide association studies.

Sato Y, Tajima A, Katsurayama M, Nozawa S, Yoshiike M, Koh E, Kanaya J, Namiki M, Matsumiya K, Tsujimura A, Komatsu K, Itoh N, Eguchi J, Imoto I, Yamauchi A, Iwamoto T.

Hum Reprod Open. 2017 Jun 14;2017(1):hox002. doi: 10.1093/hropen/hox002. eCollection 2017. Erratum in: Hum Reprod Open. 2017 Jun 14;2017(1):hox005.

18.

Erratum: An independent validation study of three single nucleotide polymorphisms at the sex hormone-binding globulin locus for testosterone levels identified by genome-wide association studies.

Sato Y, Tajima A, Katsurayama M, Nozawa S, Yoshiike M, Koh E, Kanaya J, Namiki M, Matsumiya K, Tsujimura A, Komatsu K, Itoh N, Eguchi J, Imoto I, Yamauchi A, Iwamoto T.

Hum Reprod Open. 2017 Jun 14;2017(1):hox005. doi: 10.1093/hropen/hox005. eCollection 2017.

19.

Marked hypertriglyceridemia induced by interferon-β1a therapy in a clinically isolated syndrome patient.

Kawahara Y, Yamashita T, Ohta Y, Sato K, Tsunoda K, Takemoto M, Hishikawa N, Eguchi J, Abe K.

J Neurol Sci. 2017 Feb 15;373:144-146. doi: 10.1016/j.jns.2016.12.052. Epub 2016 Dec 27. No abstract available.

PMID:
28131174
20.

Inhibition of SGLT2 alleviates diabetic nephropathy by suppressing high glucose-induced oxidative stress in type 1 diabetic mice.

Hatanaka T, Ogawa D, Tachibana H, Eguchi J, Inoue T, Yamada H, Takei K, Makino H, Wada J.

Pharmacol Res Perspect. 2016 May 30;4(4):e00239. doi: 10.1002/prp2.239. eCollection 2016 Aug.

21.

Calcineurin inhibitor- and corticosteroid-free immunosuppression in pediatric heart transplant patients.

Sierra CM, Tan R, Eguchi J, Bailey L, Chinnock RE.

Pediatr Transplant. 2017 Feb;21(1). doi: 10.1111/petr.12808. Epub 2016 Sep 23.

PMID:
27658616
22.

IRF3 promotes adipose inflammation and insulin resistance and represses browning.

Kumari M, Wang X, Lantier L, Lyubetskaya A, Eguchi J, Kang S, Tenen D, Roh HC, Kong X, Kazak L, Ahmad R, Rosen ED.

J Clin Invest. 2016 Aug 1;126(8):2839-54. doi: 10.1172/JCI86080. Epub 2016 Jul 11.

23.

A replication study of a candidate locus for follicle-stimulating hormone levels and association analysis for semen quality traits in Japanese men.

Sato Y, Tajima A, Katsurayama M, Nozawa S, Yoshiike M, Koh E, Kanaya J, Namiki M, Matsumiya K, Tsujimura A, Komatsu K, Itoh N, Eguchi J, Imoto I, Yamauchi A, Iwamoto T.

J Hum Genet. 2016 Nov;61(11):911-915. doi: 10.1038/jhg.2016.82. Epub 2016 Jun 30.

PMID:
27357427
24.

Antiobesity Action of ACAM by Modulating the Dynamics of Cell Adhesion and Actin Polymerization in Adipocytes.

Murakami K, Eguchi J, Hida K, Nakatsuka A, Katayama A, Sakurai M, Choshi H, Furutani M, Ogawa D, Takei K, Otsuka F, Wada J.

Diabetes. 2016 May;65(5):1255-67. doi: 10.2337/db15-1304. Epub 2016 Mar 8.

25.

Insufficiency of phosphatidylethanolamine N-methyltransferase is risk for lean non-alcoholic steatohepatitis.

Nakatsuka A, Matsuyama M, Yamaguchi S, Katayama A, Eguchi J, Murakami K, Teshigawara S, Ogawa D, Wada N, Yasunaka T, Ikeda F, Takaki A, Watanabe E, Wada J.

Sci Rep. 2016 Feb 17;6:21721. doi: 10.1038/srep21721.

26.

The gender specific risk factors for prolonged hospitalization due to acute pyelonephritis in a Japanese tertiary emergency center.

Muneishi R, Tanimoto R, Wada K, Hsiao P, Eguchi J, Araki M, Watanabe T, Nasu Y, Akebi N.

J Infect Chemother. 2016 Feb;22(2):108-11. doi: 10.1016/j.jiac.2015.11.007. Epub 2015 Dec 23.

PMID:
26712583
27.

Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis.

Katayama A, Nakatsuka A, Eguchi J, Murakami K, Teshigawara S, Kanzaki M, Nunoue T, Hida K, Wada N, Yasunaka T, Ikeda F, Takaki A, Yamamoto K, Kiyonari H, Makino H, Wada J.

Sci Rep. 2015 Nov 19;5:16920. doi: 10.1038/srep16920.

28.

Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.

Yutani S, Ueshima K, Abe K, Ishiguro A, Eguchi J, Matsueda S, Komatsu N, Shichijo S, Yamada A, Itoh K, Sasada T, Kudo M, Noguchi M.

J Immunol Res. 2015;2015:473909. doi: 10.1155/2015/473909. Epub 2015 Oct 11.

29.

Single-incision cholecystectomy in a patient with situs inversus totalis presenting with cholelithiasis: A case report.

Deguchi Y, Mitamura K, Omotaka S, Eguchi J, Sakuma D, Sato M, Nomura N, Ito T, Grimes KL, Inoue H.

Asian J Endosc Surg. 2015 Aug;8(3):347-9. doi: 10.1111/ases.12180.

PMID:
26303735
30.

An association study of four candidate loci for human male fertility traits with male infertility.

Sato Y, Tajima A, Tsunematsu K, Nozawa S, Yoshiike M, Koh E, Kanaya J, Namiki M, Matsumiya K, Tsujimura A, Komatsu K, Itoh N, Eguchi J, Imoto I, Yamauchi A, Iwamoto T.

Hum Reprod. 2015 Jun;30(6):1510-4. doi: 10.1093/humrep/dev088. Epub 2015 Apr 23.

PMID:
25908656
31.

Lack of replication of four candidate SNPs implicated in human male fertility traits: a large-scale population-based study.

Sato Y, Tajima A, Tsunematsu K, Nozawa S, Yoshiike M, Koh E, Kanaya J, Namiki M, Matsumiya K, Tsujimura A, Komatsu K, Itoh N, Eguchi J, Imoto I, Yamauchi A, Iwamoto T.

Hum Reprod. 2015 Jun;30(6):1505-9. doi: 10.1093/humrep/dev081. Epub 2015 Apr 23.

PMID:
25908655
32.

Y chromosome haplogroup D2a1 is significantly associated with high levels of luteinizing hormone in Japanese men.

Sato Y, Shinka T, Nozawa S, Yoshiike M, Koh E, Kanaya J, Namiki M, Matsumiya K, Tsujimura A, Komatsu K, Itoh N, Eguchi J, Yamauchi A, Iwamoto T, Nakahori Y.

Andrology. 2015 May;3(3):520-5. doi: 10.1111/andr.12026. Epub 2015 Apr 8.

33.

Translocase of inner mitochondrial membrane 44 alters the mitochondrial fusion and fission dynamics and protects from type 2 diabetes.

Wang Y, Katayama A, Terami T, Han X, Nunoue T, Zhang D, Teshigawara S, Eguchi J, Nakatsuka A, Murakami K, Ogawa D, Furuta Y, Makino H, Wada J.

Metabolism. 2015 Jun;64(6):677-88. doi: 10.1016/j.metabol.2015.02.004. Epub 2015 Feb 23.

PMID:
25749183
34.

Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes.

Higuchi C, Nakatsuka A, Eguchi J, Teshigawara S, Kanzaki M, Katayama A, Yamaguchi S, Takahashi N, Murakami K, Ogawa D, Sasaki S, Makino H, Wada J.

Metabolism. 2015 Apr;64(4):489-97. doi: 10.1016/j.metabol.2014.12.003. Epub 2014 Dec 18.

PMID:
25726255
35.

Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer's disease.

Fukunaga K, Sakai D, Watanabe K, Nakayama K, Kohara T, Tanaka H, Sunada S, Nabeno M, Okamoto M, Saito K, Eguchi J, Mori A, Tanaka S, Inazawa K, Horikawa T.

Bioorg Med Chem Lett. 2015 Mar 1;25(5):1086-91. doi: 10.1016/j.bmcl.2015.01.005. Epub 2015 Jan 13.

PMID:
25655721
36.

Increased expression of immuno-inhibitory molecules on peripheral blood lymphocytes may suppress disease progression in autoimmune hepatitis.

Hiraide-Sasagawa A, Hiroishi K, Shimazaki T, Eguchi J, Ishii S, Morikawa K, Sakaki M, Doi H, Omori R, Kajiwara A, Hayashi E, Shiina M, Hirayama Y, Imawari M.

Hepatol Res. 2015 Nov;45(11):1152-4. doi: 10.1111/hepr.12479. No abstract available.

PMID:
25581267
37.

Structural design and synthesis of arylalkynyl amide-type peroxisome proliferator-activated receptor γ (PPARγ)-selective antagonists based on the helix12-folding inhibition hypothesis.

Ohashi M, Gamo K, Tanaka Y, Waki M, Beniyama Y, Matsuno K, Wada J, Tenta M, Eguchi J, Makishima M, Matsuura N, Oyama T, Miyachi H.

Eur J Med Chem. 2015 Jan 27;90:53-67. doi: 10.1016/j.ejmech.2014.11.017. Epub 2014 Nov 7.

PMID:
25461311
38.

Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.

Terami N, Ogawa D, Tachibana H, Hatanaka T, Wada J, Nakatsuka A, Eguchi J, Horiguchi CS, Nishii N, Yamada H, Takei K, Makino H.

PLoS One. 2014 Jun 24;9(6):e100777. doi: 10.1371/journal.pone.0100777. eCollection 2014.

39.

Y chromosome gr/gr subdeletion is associated with lower semen quality in young men from the general Japanese population but not in fertile Japanese Men.

Sato Y, Iwamoto T, Shinka T, Nozawa S, Yoshiike M, Koh E, Kanaya J, Namiki M, Matsumiya K, Tsujimura A, Komatsu K, Itoh N, Eguchi J, Yamauchi A, Nakahori Y.

Biol Reprod. 2014 Jun;90(6):116. doi: 10.1095/biolreprod.114.118810. Epub 2014 Apr 23.

PMID:
24759788
40.

Pemt deficiency ameliorates endoplasmic reticulum stress in diabetic nephropathy.

Watanabe M, Nakatsuka A, Murakami K, Inoue K, Terami T, Higuchi C, Katayama A, Teshigawara S, Eguchi J, Ogawa D, Watanabe E, Wada J, Makino H.

PLoS One. 2014 Mar 25;9(3):e92647. doi: 10.1371/journal.pone.0092647. eCollection 2014.

41.

Nuclear hormone receptor expression in mouse kidney and renal cell lines.

Ogawa D, Eguchi J, Wada J, Terami N, Hatanaka T, Tachibana H, Nakatsuka A, Horiguchi CS, Nishii N, Makino H.

PLoS One. 2014 Jan 22;9(1):e85594. doi: 10.1371/journal.pone.0085594. eCollection 2014.

42.

2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors.

Fukunaga K, Uehara F, Aritomo K, Shoda A, Hiki S, Okuyama M, Usui Y, Watanabe K, Yamakoshi K, Kohara T, Hanano T, Tanaka H, Tsuchiya S, Sunada S, Saito K, Eguchi J, Yuki S, Asano S, Tanaka S, Mori A, Yamagami K, Baba H, Horikawa T, Fujimura M.

Bioorg Med Chem Lett. 2013 Dec 15;23(24):6933-7. doi: 10.1016/j.bmcl.2013.09.020. Epub 2013 Sep 21.

PMID:
24176395
43.

Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes.

Terami T, Wada J, Inoue K, Nakatsuka A, Ogawa D, Teshigawara S, Murakami K, Katayama A, Eguchi J, Makino H.

Int J Nephrol Renovasc Dis. 2013 Oct 22;6:233-40. doi: 10.2147/IJNRD.S51829. eCollection 2013.

44.

Metallothionein deficiency exacerbates diabetic nephropathy in streptozotocin-induced diabetic mice.

Tachibana H, Ogawa D, Sogawa N, Asanuma M, Miyazaki I, Terami N, Hatanaka T, Horiguchi CS, Nakatsuka A, Eguchi J, Wada J, Yamada H, Takei K, Makino H.

Am J Physiol Renal Physiol. 2014 Jan 1;306(1):F105-15. doi: 10.1152/ajprenal.00034.2013. Epub 2013 Oct 23.

45.

Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray.

Inoue K, Wada J, Eguchi J, Nakatsuka A, Teshigawara S, Murakami K, Ogawa D, Terami T, Katayama A, Tone A, Iseda I, Hida K, Yamada M, Ogawa T, Makino H.

PLoS One. 2013 Oct 15;8(10):e77118. doi: 10.1371/journal.pone.0077118. eCollection 2013.

46.

6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3β inhibitors.

Uehara F, Shoda A, Aritomo K, Fukunaga K, Watanabe K, Ando R, Shinoda M, Ueno H, Kubodera H, Sunada S, Saito K, Kaji T, Asano S, Eguchi J, Yuki S, Tanaka S, Yoneyama Y, Niwa T.

Bioorg Med Chem Lett. 2013 Dec 15;23(24):6928-32. doi: 10.1016/j.bmcl.2013.09.021. Epub 2013 Sep 17.

PMID:
24094818
47.

Interferon regulatory factor 4 regulates obesity-induced inflammation through regulation of adipose tissue macrophage polarization.

Eguchi J, Kong X, Tenta M, Wang X, Kang S, Rosen ED.

Diabetes. 2013 Oct;62(10):3394-403. doi: 10.2337/db12-1327. Epub 2013 Jul 8.

48.

Semen quality of 1559 young men from four cities in Japan: a cross-sectional population-based study.

Iwamoto T, Nozawa S, Mieno MN, Yamakawa K, Baba K, Yoshiike M, Namiki M, Koh E, Kanaya J, Okuyama A, Matsumiya K, Tsujimura A, Kanetake H, Eguchi J, Skakkebaek NE, Vierula M, Toppari J, Jørgensen N.

BMJ Open. 2013 Apr 29;3(4). pii: e002222. doi: 10.1136/bmjopen-2012-002222. Print 2013.

49.

Intraosseous schwannoma originating in inferior alveolar nerve: a case report.

Suga K, Ogane S, Muramatsu K, Ohata H, Uchiyama T, Takano N, Shibahara T, Eguchi J, Murakami S, Matsuzaka K.

Bull Tokyo Dent Coll. 2013;54(1):19-25.

50.

Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease.

Kurose Y, Wada J, Kanzaki M, Teshigawara S, Nakatsuka A, Murakami K, Inoue K, Terami T, Katayama A, Watanabe M, Higuchi C, Eguchi J, Miyatake N, Makino H.

BMC Nephrol. 2013 Jan 22;14:23. doi: 10.1186/1471-2369-14-23.

Supplemental Content

Loading ...
Support Center